Ask AI
Bill118th CongressFiled Jun 7, 2023Health
H.R. 3884

Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023

Bill journey · stage 2 of 5

Under committee review

Filed
Comm.
Floor
Both
Law

What it does

A plain-language summary from the Congressional Research Service isn’t available yet for this bill. CRS summaries are typically posted within a few weeks of introduction.

What just happenedSep 24, 2024

Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Who’s behind it

Rep. Burgess, Michael C. [R-TX-26](R-TX)Sponsor
3 cosponsors2 D1 R
Read on Congress.gov
3cosponsors2committees18actions5subjects
  1. Sep 24, 2024IntroReferral

    Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

    Health, Education, Labor, and Pensions Committee
  2. Sep 23, 2024FloorH38310

    Motion to reconsider laid on the table Agreed to without objection.

  3. Sep 23, 2024FloorH37300

    On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5578)

  4. Sep 23, 2024Floor8000

    Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5578)

  5. Sep 23, 2024FloorH8D000

    DEBATE - The House proceeded with forty minutes of debate on H.R. 3884.

  6. Sep 23, 2024FloorH30000

    Considered under suspension of the rules. (consideration: CR H5578-5580)

  7. Sep 23, 2024FloorH30300

    Mr. Bucshon moved to suspend the rules and pass the bill, as amended.

  8. Aug 25, 2023CalendarsH12410

    Placed on the Union Calendar, Calendar No. 132.

  9. Aug 25, 2023CommitteeH12200

    Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-166.

    Energy and Commerce Committee
  10. Aug 25, 2023Committee5000

    Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-166.

    Energy and Commerce Committee
  11. Jul 19, 2023Committee

    Ordered to be Reported (Amended) by the Yeas and Nays: 50 - 0.

    Energy and Commerce Committee
  12. Jul 19, 2023Committee

    Committee Consideration and Mark-up Session Held.

    Energy and Commerce Committee
  13. Jul 13, 2023Committee

    Subcommittee Consideration and Mark-up Session Held

    Health Subcommittee
  14. Jul 13, 2023Committee

    Forwarded by Subcommittee to Full Committee (Amended) by the Yeas and Nays: 28 - 0.

    Health Subcommittee
  15. Jun 9, 2023Committee

    Referred to the Subcommittee on Health.

    Health Subcommittee
  16. Jun 7, 2023IntroReferralH11100

    Referred to the House Committee on Energy and Commerce.

    Energy and Commerce Committee
  17. Jun 7, 2023IntroReferralIntro-H

    Introduced in House

  18. Jun 7, 2023IntroReferral1000

    Introduced in House

Reported to HouseAug 25, 20237
Introduced in HouseJun 7, 2023
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention… — Informed